Related Experiment Video
Updated: Aug 3, 2026

Transthoracic Speckle Tracking Echocardiography for the Quantitative Assessment of Left Ventricular Myocardial Deformation
Published on: October 20, 2016
Early and subtle abnormalities of left ventricular function in clinically stable coronary artery disease patients
R Bolognesi1, D Tsialtas, R Zeppellini
1Cattedra di Cardiologia, Università degli Studi di Parma, Parma, Italy.
Insights
Early ischemic cardiomyopathy shows subtle systolic and diastolic dysfunction in coronary artery disease patients with normal ejection fraction, indicating potential for early detection.
Area of Science:
- Cardiology
- Cardiovascular Physiology
Background:
- Ischemic cardiomyopathy's initial phase may present early left ventricular (LV) function alterations during relaxation.
- Detecting precocious abnormalities in both LV systolic and diastolic phases is crucial for early intervention.
Purpose of the Study:
- To identify early systolic and diastolic abnormalities in patients with coronary artery disease (CAD) and normal LV ejection fraction.
Main Methods:
- Simultaneous left ventricular catheterization and echo-Doppler techniques were employed.
- Systolic and diastolic functions were assessed in 44 stable CAD patients with normal ejection fraction and 9 controls.
Main Results:
- CAD patients exhibited significantly prolonged E deceleration time, tau, and elevated LV end-diastolic volume and pressure.
- LV end-systolic volume and lowest diastolic pressure were higher, while mean dP/dt/P values were lower in CAD patients compared to controls.
- A strong correlation was observed between dP/dt/P, tau, and LV pressures in all subjects.
Conclusions:
- Subtle abnormalities in systolic and diastolic function parameters are detectable in most CAD patients with preserved ejection fraction.
- These findings suggest that early detection of cardiac dysfunction is possible even before significant ejection fraction decline.
Background:
It has been reported that, in the initial phase of ischemic cardiomyopathy, the earliest alterations of left ventricular function are detected during the relaxation phase. The aim of this study was to look for precocious abnormalities in the early stage of ischemic cardiomyopathy in both left ventricular systolic and diastolic phases.
Methods And Results:
Using simultaneous left ventricular catheterization and echo-Doppler techniques, we studied both systolic and diastolic function in 44 (37 males and 7 females, mean age 55.7+/-8) normotensive, clinically stable, coronary artery disease patients with normal left ventricular ejection fraction in comparison to 9 age- and sex-matched normal control subjects (7 males and 2 females, mean age 54.7+/-9). Mean values of E deceleration time, tau, left ventricular end-diastolic volume and pressure, and end-systolic volume and lowest diastolic pressure were significantly higher (from P<.05 to P<.01), whereas mean dP/dt/P values significantly lower (P<.05) in coronary artery disease patients than in controls. A strict relationship (P<.001) between dP/dt/P and tau, left ventricular lowest and end-diastolic pressure was found in all subjects studied.
Conclusion:
Early and subtle abnormalities in parameters of both systolic and diastolic function can be found in the majority of coronary artery disease patients with normal ejection fraction.
Related Concept Videos
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy

